The US FDA has approved CorMedix for the treatment of bloodstream infections

US health regulators on Wednesday approved CorMedix’s antimicrobial drug to reduce catheter-associated bloodstream infections in patients with kidney disease, allowing the company to launch its first commercial product.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM